An Appeal Court confirmed legitimacy of a 200-million RUB fine imposed upon “Pharmstandart” OJSC for bid-rigging

27-03-2014 | 18:20

On 24th March 2014, the 9th Arbitration Appeal Court pronounced legitimacy of holding “Pharmstandart” OJSC administratively liable and fining the company over 201 million RUB.

In 2009, the Ministry of Health Care and Social Development organized a tender for centralized procurement of “Pulmozyme” for the state needs. The medicine is used for treatment of some chronic pulmonary diseases (congenital lung defects, chronic pneumonias, immunodeficiencies with lung damage, etc.)

In 2012, the FAS Commission established that “Rosta” CJSC and “Pharmstandart” OJSC had concluded and implemented an agreement that resulted in maintaining prices at the tender at the maximum possible level and found that the companies had violated Clause 2 Part 1 Article 11 of the Federal Law “On Protection of Competition”. Courts supported this decision.

The total fines imposed by the Federal Antimonopoly Service upon “Rosta” CJSC and “Pharmstandart” OJSC for participating in the cartel reached 402 million RUB.

Earlier the 9th Arbitration Appeal Court also pronounced legitimacy of the fine imposed upon another cartel participant – “Rosta” CJSC.


 



Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide